The Best-Practice in Oral Opioid agoniSt Therapy (BOOST) Collaborative is a Quality Improvement initiative launched by Vancouver Coastal Health (VCH) in partnership with the the BC Centre for Excellence in HIV/AIDS (BC-CfE). The purpose of the BOOST Collaborative is to improve the quality, effectiveness, and reach of oral opioid agonist therapy (oOAT) and support services in the Vancouver community to improve outcomes for people living with opioid use disorder (OUD).
The BOOST Collaborative will be piloted within the VCH Vancouver Community region and teams from primary care, mental health, substance use, withdrawal management, and outreach services will be invited to participate. OUD programs need to establish an effective, high-quality cascade of services from diagnosis and referral to care, to engagement and retention in treatment in order to improve care for people living with OUD. Establishing an OUD cascade of care will allow identification of gaps in the continuum of care that are preventing people from fully benefitting from oOAT treatment.
Why are we focusing on oOAT?
- QI requires focus: to create system change we must focus on specific aspects of care along the continuum of care for people with OUD.
- QI does not generate new knowledge: QI brings existing knowledge into practice and oOAT is where we have the best evidence and data that will help us drive change.
- QI is a journey of small steps: we know not everybody benefits from oOAT but optimizing care for those who will benefit, will allow us to identify those who need other types of interventions.
Please visit our Tools and Resources page for more details.